The University of Maryland Medical System (UMMS) partners with Maryland Public Television (MPT) for a special series called "Your Health," which features UMMS specialists who share their medical expertise with viewers all across Maryland.
UMMS guests appear every other week in a special "Your Health" segment on MPT's program "Direct Connection," airing live Monday nights at 7:30 p.m.
The show takes calls from viewers, so you have the opportunity to speak directly to our experts and get your questions answered.
Miss the show? Watch all segments in the below playlist.
See all previous Your Health segments »
Next "Your Health" Guest
"Harnessing the Body's Immune System to Treat Cancer"
Monday, September 25
7:30pm on MPT's Direct Connection "Your Health"
Immunotherapy is showing great promise in treating a number of cancers, and the U.S. Food and Drug Administration recently approved the first gene-altering therapy to spur the patient’s own immune cells to recognize and attack their cancer. This treatment, known as CAR T-cell therapy, was approved for children and young adults with an aggressive type of leukemia.
Dr. Aaron Rapoport, a hematologist/oncologist who directs the Blood and Marrow Transplant Program at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, has been studying immunotherapy to treat blood cancers for the past two decades. He will discuss the potential benefits as well as the possible side effects and what the FDA’s action means for cancer patients.
Do you have a question about immunotherapy to treat cancer? Send us your question via Twitter @MPTNews #yourhealth. Then watch Direct Connection on September 25, 2017, at 7:30 p.m. to see if we use your question on the show.
Dr. Aaron Rapoport
Gary Jobson Professor in Medical Oncology
University of Maryland School of Medicine
Director of the Blood and Marrow Transplant Program
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center